Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 13 | $20,736,165 |
Sells | 120 | $101,205,948 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 285,046 | 26 | 7,411,196 | D |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 233,362 | 26 | 6,067,412 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 126,066 | 41.94 | 5,287,208 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 126,066 | 41.94 | 5,287,208 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 108,404 | 42.19 | 4,573,565 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 108,404 | 42.19 | 4,573,565 | D |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 112,819 | 30.28 | 3,416,159 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 112,819 | 30.28 | 3,416,159 | D |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 101,189 | 31.44 | 3,181,382 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 101,189 | 31.44 | 3,181,382 | D |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 02 Nov 2022 | Sale | 96,581 | 30.02 | 2,899,362 | D |
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 02 Nov 2022 | Sale | 96,581 | 30.02 | 2,899,362 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 31 Oct 2022 | Sale | 94,239 | 30.23 | 2,848,845 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 31 Oct 2022 | Sale | 94,239 | 30.23 | 2,848,845 | I |
13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Jan 2023 | Sale | 77,128 | 30.29 | 2,336,207 | D |
13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jan 2023 | Sale | 77,128 | 30.29 | 2,336,207 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 03 Nov 2022 | Sale | 75,312 | 30 | 2,259,360 | D |
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 03 Nov 2022 | Sale | 75,312 | 30 | 2,259,360 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 28 Oct 2022 | Sale | 71,135 | 30 | 2,134,050 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 28 Oct 2022 | Sale | 71,135 | 30 | 2,134,050 | I |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 49,591 | 40.62 | 2,014,386 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 54,737 | 32.33 | 1,769,647 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 54,737 | 32.33 | 1,769,647 | D |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 56,455 | 30.57 | 1,725,829 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 56,455 | 30.57 | 1,725,829 | I |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 37,180 | 42.77 | 1,590,189 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 37,180 | 42.77 | 1,590,189 | D |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 132,016 | 11.6444 | 1,537,247 | D |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 103,885 | 14.0689 | 1,461,548 | D |
09 Feb 2024 19:47 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 09 Feb 2024 | Sale | 38,739 | 35.3922 | 1,371,058 | D |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 34,473 | 39.73 | 1,369,612 | I |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 83,708 | 14.0689 | 1,177,679 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 26,452 | 41.94 | 1,109,397 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 26,452 | 41.94 | 1,109,397 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 22,779 | 42.19 | 961,046 | I |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 22,779 | 42.19 | 961,046 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 31,584 | 30.28 | 956,364 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 31,584 | 30.28 | 956,364 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 28,329 | 31.44 | 890,664 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 28,329 | 31.44 | 890,664 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 02 Nov 2022 | Sale | 27,038 | 30.02 | 811,681 | I |
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 02 Nov 2022 | Sale | 27,038 | 30.02 | 811,681 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 31 Oct 2022 | Sale | 26,383 | 30.23 | 797,558 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 31 Oct 2022 | Sale | 26,383 | 30.23 | 797,558 | I |
23 Aug 2022 17:35 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 22 Aug 2022 | Purchase | 27,117 | 26 | 705,042 | D |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 57,618 | 11.6444 | 670,927 | D |
13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Jan 2023 | Sale | 21,592 | 30.29 | 654,022 | I |
13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jan 2023 | Sale | 21,592 | 30.29 | 654,022 | I |
13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Jan 2023 | Sale | 21,683 | 29.96 | 649,623 | D |
13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Jan 2023 | Sale | 21,683 | 29.96 | 649,623 | I |
04 Nov 2022 16:30 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 03 Nov 2022 | Sale | 21,085 | 30 | 632,550 | I |
04 Nov 2022 16:31 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 03 Nov 2022 | Sale | 21,085 | 30 | 632,550 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 28 Oct 2022 | Sale | 19,915 | 30 | 597,450 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 28 Oct 2022 | Sale | 19,915 | 30 | 597,450 | I |
13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 12 Jan 2023 | Purchase | 15,912 | 31.2426 | 497,132 | D |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 15,324 | 32.33 | 495,425 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 15,324 | 32.33 | 495,425 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 15,804 | 30.57 | 483,128 | I |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 15,804 | 30.57 | 483,128 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 13,997 | 33.34 | 466,660 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 13,997 | 33.34 | 466,660 | D |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 13,335 | 34.02 | 453,657 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 13,335 | 34.02 | 453,657 | D |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 10,846 | 40.66 | 440,998 | I |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 10,411 | 40.62 | 422,895 | I |
14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jun 2024 | Sale | 11,838 | 35.35 | 418,473 | I |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 8,581 | 42.52 | 364,864 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 12 Mar 2024 | Sale | 8,581 | 42.52 | 364,864 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 7,837 | 42.77 | 335,188 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 7,837 | 42.77 | 335,188 | I |
13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 11 Jan 2023 | Purchase | 11,149 | 29.8869 | 333,209 | D |
13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 11 Jan 2023 | Purchase | 10,961 | 29.8869 | 327,590 | D |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 15 Mar 2024 | Sale | 8,126 | 39.31 | 319,433 | I |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 02 Nov 2023 | Purchase | 26,772 | 11.6444 | 311,744 | D |
23 Jan 2024 19:37 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 23 Jan 2024 | Sale | 10,000 | 30.047 | 300,470 | D |
14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Jun 2024 | Sale | 8,430 | 34.98 | 294,881 | I |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 7,292 | 39.73 | 289,711 | I |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 13 Mar 2024 | Sale | 6,686 | 42.84 | 286,428 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 13 Mar 2024 | Sale | 6,686 | 42.84 | 286,428 | D |
09 Feb 2024 19:47 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 09 Feb 2024 | Sale | 7,398 | 36.0926 | 267,013 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Mar 2024 | Sale | 5,122 | 43.42 | 222,397 | I |
13 Mar 2024 19:53 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Mar 2024 | Sale | 5,122 | 43.42 | 222,397 | D |
07 Jun 2024 18:36 | KYMR | Kymera Therapeutics Inc | HOROBIN JOANNA | Director | 07 Jun 2024 | Sale | 6,313 | 33.1071 | 209,005 | D |
13 Jan 2023 16:50 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 11 Jan 2023 | Sale | 6,071 | 29.96 | 181,887 | I |
13 Jan 2023 16:53 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 11 Jan 2023 | Sale | 6,071 | 29.96 | 181,887 | I |
21 Feb 2024 18:46 | KYMR | Kymera Therapeutics Inc | ALBERS JEFFREY W. | Director | 21 Feb 2024 | Sale | 4,385 | 39.0483 | 171,227 | D |
06 Nov 2023 18:07 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 03 Nov 2023 | Purchase | 10,106 | 14.0689 | 142,180 | D |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 3,919 | 33.34 | 130,659 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 3,919 | 33.34 | 130,659 | I |
16 Dec 2022 17:05 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Dec 2022 | Sale | 3,733 | 34.02 | 126,997 | I |
16 Dec 2022 17:03 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 14 Dec 2022 | Sale | 3,733 | 34.02 | 126,997 | I |
01 Nov 2022 19:34 | KYMR | Kymera Therapeutics Inc | ATLAS VENTURE FUND X, L.P. | 10% | 01 Nov 2022 | Sale | 3,727 | 31.08 | 115,835 | D |
01 Nov 2022 19:36 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 01 Nov 2022 | Sale | 3,727 | 31.08 | 115,835 | I |
04 Mar 2024 18:12 | KYMR | Kymera Therapeutics Inc | JACOBS BRUCE N. | Chief Financial Officer | 04 Mar 2024 | Sale | 2,378 | 41.4135 | 98,481 | D |
13 Jan 2023 17:08 | KYMR | Kymera Therapeutics Inc | BVF PARTNERS L P/IL | Director | 12 Jan 2023 | Purchase | 2,985 | 31.2426 | 93,259 | D |
15 Mar 2024 19:23 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 14 Mar 2024 | Sale | 2,233 | 40.66 | 90,794 | I |
23 May 2024 16:10 | KYMR | Kymera Therapeutics Inc | CHADWICK JEREMY G | Chief Operating Officer | 23 May 2024 | Sale | 2,575 | 34.9921 | 90,105 | D |
14 Jun 2024 18:01 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Jun 2024 | Sale | 2,485 | 35.35 | 87,845 | I |
04 Mar 2024 18:21 | KYMR | Kymera Therapeutics Inc | GOLLOB JARED | Chief Medical Officer | 04 Mar 2024 | Sale | 2,022 | 41.4135 | 83,738 | D |
13 Mar 2024 19:52 | KYMR | Kymera Therapeutics Inc | BOOTH BRUCE | Director | 12 Mar 2024 | Sale | 1,819 | 42.52 | 77,344 | I |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)